SCHEDULE 13GAccepted Oct 15, 4:07 PM ET
ArriVent BioPharma, Inc. SCHEDULE 13G
Accepted (ET)
4:07 PM
Oct 15, 2025
Filed
Oct 15, 2025
Documents
1
Size
7.9 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.